Tuesday 2nd December – Day 2 Main Conference - GMT (Greenwich Mean Time, GMTZ)
- Ian Rees - Assessor, MHRA
- Karin Hoogendoorn - Head Drug Product Development (CART, Oncology), Galapagos BV
- Malin Stridh - General Manager, MIDA Biotech B.V.
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: RShah@informaconnectls.com
- Mehdi Gasmi - COO/CSO, SparingVision
- Christine Le Bec - Deputy CTO, Head of Analytical Development & QC, Sensorion
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: RShah@informaconnectls.com
- Karin Hoogendoorn - Head Drug Product Development (CART, Oncology), Galapagos BV
- Evaluating opportunities to integrate AI in CGT manufacturing
- Building data governance frameworks for verification & validation
- Developing more robust, adaptive to specific biology of cell therapies models
- Integration of AI process development and manufacturing
- Predictive analytics for CMC and manufacturing optimization
- AI-driven process development and real-time lot release
- Machine learning and digital twins: Applications & validation
- Overcoming challenges with limited data for AI models
- Data-centric processing: Integrating AI into CGT workflows
- Case study on AI-driven manufacturing success
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: RShah@informaconnectls.com
- Gonzalo Fernández-Miranda - CEO and Co-Founder, CureAge Therapeutics
- Development of robust LNP delivery systems
- Optimising LNP engineering to minimize off site delivery
- Overcoming scalability and reproducibility challenges
- Critical parameters influencing LNP manufacturing efficiency, consistency, and scalability
- Optimising LNP formulation design
- Analytical control strategy for LNPs
- Manufacturing innovation: Reducing cold-chain dependence & improving temperature stability
- Supply chain considerations for commercial viability
- Case Study: Successful LNP Scale-Up
Spotlight Presentation – Calling all Technology Thought Leaders!
Whether you're increasing your company profile, launching a new product or focusing on new business development opportunities, collaborate with us to identify custom solutions to help you reach your goals.
Contact us today to learn more: RShah@informaconnectls.com
- Strategies to shorten clinical development with compromising patient safety and product quality
- Design strategies for clinical trials
- Clinical endpoints – Key to success
- How to address clinical trial design for association therapies?
- Eric Halioua - President & Chief Executive Officer, PDC*line Pharma
- Round Table 1: AI Revolution in CGT Manufacturing – Beyond the Hype: Where is it Having an Impact?
- Round Table 2: From Rare Diseases to Mainstream Markets: Unlocking CGT's Potential for Major Disease Indications
Leader: Hiroyuki Usuda, Scouting & Transaction Lead, Business Development, Astellas Pharma Europe Ltd
- Round Table 3: Supply Chain Mastery: Architecting Success from Bench to Market
- Hiroyuki Usuda - Scouting & Transaction Lead, Business Development, Astellas Pharma Europe Ltd
- Dmitry Kalupin - CEO, Unlock Biology
- Christopher Bravery, Ph.D. - Consulting Regulatory Scientist, Advbiols
- Wenshi Wang - SVP Tech & Ops, FosunKairos
- Wenshi Wang - SVP Tech & Ops, FosunKairos
- Martina Ochel - Chief Operating Officer, CuraCell
- Bernd Muehlenweg - SVP, Head of Global Business Development, Cell Therapy - Global BD iPSC Cell Therapy, Evotec
This critical panel discussion brings together experts to explore the evolving regulatory frameworks affecting cell and gene therapy development in Europe.
- Alexander Natz - Secretary General, European Confederation of Pharmaceutical Entrepreneurs (EUCOPE)